Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Clinical T1-2N0 ER+ Her2- Breast Cancer With Ultrasound Detected Nodal Metastases

NCT06092892 is registered in ClinicalTrials.gov with Alice Chung as lead sponsor.

NCT NCT06092892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06092892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Clinical T1-2N0 ER+ Her2- Breast Cancer With Ultrasound Detected Nodal Metastases
Lead sponsor
Alice Chung
Phase
Phase 2
Overall status
Recruiting
Start date
April 7, 2024
Completion date
April 30, 2031
Enrollment
45 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

axilla; breast, axillary nodal disease, breast cancer, female breast cancer, mastectomy; lymphedema, tumor, breast